These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10188911)

  • 1. Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor.
    Horti J; Dixon SC; Logothetis CJ; Guo Y; Reed E; Figg WD
    Br J Cancer; 1999 Mar; 79(9-10):1588-93. PubMed ID: 10188911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-tumor effects of an angiogenesis inhibitor, TNP-470 (AGM-1470) alone and in combination with cisplatinum, and changes in serum copper levels in liver cancer bearing rats].
    Matsuoka S
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):69-80. PubMed ID: 8727376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
    Yamaoka M; Yamamoto T; Masaki T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Sep; 53(18):4262-7. PubMed ID: 7689930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
    Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
    Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenesis inhibitor TNP-470 (AGM-1470) improves long-term survival of rats with liver metastasis.
    Ahmed MH; Konno H; Nahar L; Tanaka T; Naito Y; Nakamura S; Baba S
    J Surg Res; 1996 Jul; 64(1):35-41. PubMed ID: 8806471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of temozolomide in a rat glioma model in the presence and absence of the angiogenesis inhibitor TNP-470.
    Devineni D; Klein-Szanto A; Gallo JM
    Cancer Res; 1996 May; 56(9):1983-7. PubMed ID: 8616836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
    Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
    Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line.
    Miki T; Nonomura N; Nozawa M; Harada Y; Nishimura K; Kojima Y; Takahara S; Okuyama A
    J Urol; 1998 Jul; 160(1):210-3. PubMed ID: 9628652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.
    Pinto JT; Sinha R; Papp K; Facompre ND; Desai D; El-Bayoumy K
    Int J Cancer; 2007 Apr; 120(7):1410-7. PubMed ID: 17205524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor effect of angiogenesis inhibitor TNP-470 on the human nasopharyngeal carcinoma cell line NPC/HK1.
    Qian CN; Min HQ; Lin HL; Feng GK; Ye YL; Wang LG; Kuang ZJ
    Oncology; 1999 Jul; 57(1):36-41. PubMed ID: 10394123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470).
    Yamamoto T; Sudo K; Fujita T
    Anticancer Res; 1994; 14(1A):1-3. PubMed ID: 7513139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of TNP-470, a new angiogenesis inhibitor.
    Figg WD; Pluda JM; Lush RM; Saville MW; Wyvill K; Reed E; Yarchoan R
    Pharmacotherapy; 1997; 17(1):91-7. PubMed ID: 9017768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Angiogenesis inhibitor (TNP-470) on the morphology of GNM cell line in vitro].
    Peng L; Li J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Jun; 20(3):175-7. PubMed ID: 12600058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells.
    Davis JN; Kucuk O; Sarkar FH
    Mol Carcinog; 2002 Jun; 34(2):91-101. PubMed ID: 12112315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
    Gunawardena K; Campbell LD; Meikle AW
    Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
    Cronauer MV; Nessler-Menardi C; Klocker H; Maly K; Hobisch A; Bartsch G; Culig Z
    Br J Cancer; 2000 Jan; 82(1):39-45. PubMed ID: 10638964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.
    Logothetis CJ; Wu KK; Finn LD; Daliani D; Figg W; Ghaddar H; Gutterman JU
    Clin Cancer Res; 2001 May; 7(5):1198-203. PubMed ID: 11350884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
    Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.